Background:The Hyperoxia Test (HT) has been proposed to quantify the shunt fraction but it is often requested as a first-line diagnostic tool, without clear guidelines on its place in the strategy for diagnosing hypoxemia.Objectives: To question the contribution of HT in managing patients with hypoxemia, taking into account comparison with morphological examinations.
Methods:We retrospectively went through on patient files referred to the Pulmonary Functional Test (PFT) laboratory from January 2016 to December 2019. Clinical, PFTs and echocardiographic data were collected.Results: 53 cases were analyzed, HT showed a shunt above 7.5 % (HT+ group) in 42 (79%). Most of patients had a preexisting pulmonary disease. Rest PaO 2 and DLCOc/VA significantly differed between HT-and HT+ Eighteen of the HT+ patients had morphological examinations, five had an anatomic abnormality. Estimated shunt fraction was negatively strongly correlated with rest PaO 2 and DLCOc/VA. When compared to a predicted exploration strategy based on shunt value and PFTs abnormalities, the actual exploration strategy showed good concordance in HT-patients and some discrepancies in HT+ ones, but most of the time, there was a clinical reason to explain why a HT+ patients was no further investigated with echocardiography.
Conclusion:HT appeared as an easy-to-do diagnostic tool in hypoxemic patients that could help to rule out pathologic shunt and to screen those eligible for more complex specialized exploration.